首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR TREATING DYSCHROMATOSIS SYMMETRICA HEREDITARIA, DYSCHROMATOSIS SYMMETRICA HEREDITARIA MODEL MOUSE, AND SCREENING METHOD FOR COMPOUND FOR TREATING DYSCHROMATOSIS SYMMETRICA HEREDITARIA

PHARMACEUTICAL COMPOSITION FOR TREATING DYSCHROMATOSIS SYMMETRICA HEREDITARIA, DYSCHROMATOSIS SYMMETRICA HEREDITARIA MODEL MOUSE, AND SCREENING METHOD FOR COMPOUND FOR TREATING DYSCHROMATOSIS SYMMETRICA HEREDITARIA

机译：用于治疗Dyschromatisis Symmetrrica噬细胞，Dyschromatiss Symmetrrica细胞模型小鼠的药物组合物，以及用于治疗DysCroomatisis Symmetrica腓虫的化合物的筛选方法

页面导航

摘要
著录项
相似文献

摘要

Provided are a pharmaceutical composition for treating dyschromatosis symmetrica hereditaria, a dyschromatosis symmetrica hereditaria model mouse, and a screening method for a compound for treating dyschromatosis symmetrica hereditaria. This pharmaceutical composition for treating dyschromatosis symmetrica hereditaria contains, as an active ingredient, at least one compound selected from the group consisting of JAK inhibitors and STAT inhibitors.

机译：提供了一种用于治疗Dyschromatosis Symmetrrica噬菌体的药物组合物，一种用于治疗Dyschromatosis Symmetrica肠胃术的化合物的筛选方法。这种用于治疗脱瘤病变Symmetrrica噬细胞的药物组合物作为活性成分，至少一种选自jak抑制剂和统计抑制剂的化合物。

著录项

公开/公告号WO2021193224A1

专利类型
公开/公告日2021-09-30

原文格式PDF
申请/专利权人 NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM;AKITA UNIVERSITY;
展开▼

申请/专利号WO2021JP10546
发明设计人 KONO MICHIHIRO;AKIYAMA MASASHI;
展开▼

申请日2021-03-16
分类号A61K45;A61P43;A61P17;C12Q1/02;C12Q1/06;G01N33/15;G01N33/48;G01N33/50;A01K67/027;A61K31/122;A61K31/167;A61K31/341;A61K31/343;A61K31/345;A61K31/352;A61K31/437;A61K31/505;A61K31/506;A61K31/519;A61K31/541;A61K31/65;A61K31/7076;
国家 JP
入库时间 2022-08-24 21:24:44

相似文献

专利
外文文献
中文文献